Published in Anticancer Drugs on October 01, 2009
Targeting the neurovascular unit for treatment of neurological disorders. Pharmacol Ther (2010) 0.85
Self-assembled squalenoyl-cytarabine nanostructures as a potent nanomedicine for treatment of leukemic diseases. Int J Nanomedicine (2012) 0.80
Nanomedicine in cerebral palsy. Int J Nanomedicine (2013) 0.80
Implications of Intrathecal Chemotherapy for Anaesthesiologists: A Brief Review. Scientifica (Cairo) (2016) 0.75
Liposomal cytarabine in neoplastic meningitis from primary brain tumors: a single institutional experience. Neurol Sci (2013) 0.75
Central Nervous System Complications in Children Receiving Chemotherapy or Hematopoietic Stem Cell Transplantation. Front Pediatr (2017) 0.75
Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol (2011) 6.67
Dissecting the genomic complexity underlying medulloblastoma. Nature (2012) 4.77
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol (2012) 3.88
FSTL5 is a marker of poor prognosis in non-WNT/non-SHH medulloblastoma. J Clin Oncol (2011) 3.33
Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol (2009) 3.01
Adjuvant dendritic cell-based tumour vaccination for children with malignant brain tumours. Pediatr Blood Cancer (2010) 2.35
Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme. Clin Cancer Res (2008) 2.04
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial. J Clin Oncol (2012) 2.01
Epidemiology and outcome of infections due to Aspergillus terreus: 10-year single centre experience. Br J Haematol (2005) 1.87
TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol (2010) 1.83
Role of radiotherapy in supratentorial primitive neuroectodermal tumor in young children: results of the German HIT-SKK87 and HIT-SKK92 trials. J Clin Oncol (2006) 1.73
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91. Eur J Cancer (2009) 1.70
Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients. Pediatr Blood Cancer (2007) 1.65
Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. J Clin Oncol (2010) 1.65
"Wait and see" strategy in localized neuroblastoma in infants: an option not only for cases detected by mass screening. Pediatr Blood Cancer (2004) 1.62
Novel polyomavirus detected in the feces of a chimpanzee by nested broad-spectrum PCR. J Virol (2005) 1.61
Cytogenetic prognostication within medulloblastoma subgroups. J Clin Oncol (2014) 1.56
Cost-effectiveness of palivizumab for respiratory syncytial virus infection in high-risk children, based on long-term epidemiologic data from Austria. Pediatr Infect Dis J (2012) 1.56
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays. Acta Neuropathol (2013) 1.50
Rolling-circle amplification of viral DNA genomes using phi29 polymerase. Trends Microbiol (2009) 1.50
Molecular stratification of medulloblastoma: comparison of histological and genetic methods to detect Wnt activated tumours. Neuropathol Appl Neurobiol (2015) 1.49
Bone marrow depletion with haemorrhagic diathesis in calves in Germany: characterization of the disease and preliminary investigations on its aetiology. Berl Munch Tierarztl Wochenschr (2010) 1.45
CNS irradiation in pediatric acute myleoid leukemia: equal results by 12 or 18 Gy in studies AML-BFM98 and 2004. Pediatr Blood Cancer (2011) 1.44
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. J Clin Oncol (2013) 1.43
Characterization of two novel polyomaviruses of birds by using multiply primed rolling-circle amplification of their genomes. J Virol (2006) 1.43
Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years' experience. Wien Klin Wochenschr (2002) 1.43
Treatment for soft tissue sarcoma in childhood and adolescence. Austrian results within the CWS 96 study. Wien Klin Wochenschr (2005) 1.39
Genome of a novel circovirus of starlings, amplified by multiply primed rolling-circle amplification. J Gen Virol (2006) 1.37
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma. Acta Neuropathol (2013) 1.35
Whole-genome characterization of a novel polyomavirus detected in fatally diseased canary birds. J Gen Virol (2010) 1.30
Treatment options in childhood pontine gliomas. J Neurooncol (2006) 1.26
Treatment of nasopharyngeal carcinoma in children and adolescents: definitive results of a multicenter study (NPC-91-GPOH). Cancer (2005) 1.26
Discovery of potent and selective agonists for the free fatty acid receptor 1 (FFA(1)/GPR40), a potential target for the treatment of type II diabetes. J Med Chem (2008) 1.25
Neuromotor noise, error tolerance and velocity-dependent costs in skilled performance. PLoS Comput Biol (2011) 1.25
Improved survival after gross total resection of malignant gliomas in pediatric patients from the HIT-GBM studies. Anticancer Res (2006) 1.24
Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients. Clin Cancer Res (2011) 1.23
Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004. Blood (2013) 1.23
Ependymoma gene expression profiles associated with histological subtype, proliferation, and patient survival. Acta Neuropathol (2007) 1.22
Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol. Cancer (2010) 1.20
Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91. Clin Cancer Res (2007) 1.18
BET bromodomain protein inhibition is a therapeutic option for medulloblastoma. Oncotarget (2013) 1.17
Charge-transfer-induced structural rearrangements at both sides of organic/metal interfaces. Nat Chem (2010) 1.16
Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer (2011) 1.16
Incidence of skeletal complications during treatment of childhood acute lymphoblastic leukemia: comparison of fracture risk with the General Practice Research Database. Pediatr Blood Cancer (2007) 1.15
Hemophagocytic lymphohistiocytosis as severe adverse event of antineoplastic treatment in children. Haematologica (2008) 1.13
Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group. Acta Neuropathol (2013) 1.12
CT and MR imaging in atypical teratoid/rhabdoid tumors of the central nervous system. Neuroradiology (2008) 1.11
Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis (2008) 1.10
Nimotuzumab for pediatric diffuse intrinsic pontine gliomas. Expert Opin Biol Ther (2010) 1.09
Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors. Pediatr Blood Cancer (2010) 1.09
Diagnosing invasive aspergillosis during antifungal therapy by PCR analysis of blood samples. J Clin Microbiol (2004) 1.08
Polyomaviruses of birds: etiologic agents of inflammatory diseases in a tumor virus family. J Virol (2007) 1.07
Detection and quantitation of group A rotaviruses by competitive and real-time reverse transcription-polymerase chain reaction. J Virol Methods (2002) 1.07
Free fatty acid receptor 1 (FFA1/GPR40) agonists: mesylpropoxy appendage lowers lipophilicity and improves ADME properties. J Med Chem (2012) 1.06
Indirect immunofluorescence assay for intra vitam diagnosis of avian bornavirus infection in psittacine birds. J Clin Microbiol (2010) 1.06
Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem. Acta Neuropathol (2012) 1.05
Supratentorial primitive neuroectodermal tumors of the central nervous system frequently harbor deletions of the CDKN2A locus and other genomic aberrations distinct from medulloblastomas. Genes Chromosomes Cancer (2007) 1.05
Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia. Br J Haematol (2014) 1.05
Ovarian small cell carcinoma of the hypercalcemic type in children and adolescents: a prognostically unfavorable but curable disease. Cancer (2006) 1.04
The genome of goose hemorrhagic polyomavirus, a new member of the proposed subgenus Avipolyomavirus. Virology (2003) 1.03
Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration. Blood (2002) 1.03
Identification of a potent and selective free fatty acid receptor 1 (FFA1/GPR40) agonist with favorable physicochemical and in vitro ADME properties. J Med Chem (2011) 1.03
Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol (2011) 1.03
Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group. J Clin Oncol (2009) 1.02
Carboxypeptidase-G2 rescue in cancer patients with delayed methotrexate elimination after high-dose methotrexate therapy. Leuk Lymphoma (2002) 1.01
Coordinate dependence of variability analysis. PLoS Comput Biol (2010) 1.01
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort. Acta Neuropathol (2014) 1.01
Prognostic significance of amplitude-integrated EEG during the first 72 hours after birth in severely asphyxiated neonates. Pediatr Res (2004) 1.00
Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report. J Neurosurg (2004) 1.00
Preradiation chemotherapy for pediatric patients with high-grade glioma. Cancer (2002) 1.00
Wound care with antibacterial honey (Medihoney) in pediatric hematology-oncology. Support Care Cancer (2005) 0.98
Treatment of young children with CNS-primitive neuroectodermal tumors/pineoblastomas in the prospective multicenter trial HIT 2000 using different chemotherapy regimens and radiotherapy. Neuro Oncol (2012) 0.97
Fusarium verticillioides abscess of the nasal septum in an immunosuppressed child: case report and identification of the morphologically atypical fungal strain. J Clin Microbiol (2005) 0.97
Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in Germany. Oncol Rep (2008) 0.97
Purinergic receptors influence the differentiation of human mesenchymal stem cells. Stem Cells Dev (2011) 0.97
Survival and late effects in children with stage 4 neuroblastoma. Pediatr Blood Cancer (2011) 0.97
C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease. Med Pediatr Oncol (2003) 0.96
Medulloblastoma. Curr Treat Options Neurol (2012) 0.95
Disintegration of large gastric lactobezoars by N-acetylcysteine. J Pediatr Gastroenterol Nutr (2010) 0.95
Norovirus outbreak in a pediatric oncology unit. Scand J Gastroenterol (2006) 0.95
Outcome of 11 children with ependymoblastoma treated within the prospective HIT-trials between 1991 and 2006. J Neurooncol (2011) 0.95
Successful treatment of progressive cutaneous mastocytosis with imatinib in a 2-year-old boy carrying a somatic KIT mutation. Blood (2008) 0.95
Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group. Br J Haematol (2008) 0.94
Challenges with defining response to antitumor agents in pediatric neuro-oncology: a report from the response assessment in pediatric neuro-oncology (RAPNO) working group. Pediatr Blood Cancer (2013) 0.93
European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies. J Antimicrob Chemother (2012) 0.93
Clinical and epidemiological characteristics of pediatric gliosarcomas. J Neurooncol (2009) 0.93
Occurrence of avian bornavirus infection in captive psittacines in various European countries and its association with proventricular dilatation disease. Avian Pathol (2011) 0.92
Actively tracking 'passive' stability in a ball bouncing task. Brain Res (2003) 0.92
Childhood medulloblastoma. Crit Rev Oncol Hematol (2010) 0.92
p53 expression predicts dismal outcome for medulloblastoma patients with metastatic disease. J Neurooncol (2011) 0.92
Findings and clinical course of a localized primitive peripheral neuroectodermal tumor of the kidney. Urol Int (2003) 0.92
Aseptic osteonecrosis in children and adolescents treated for hemato-oncologic diseases: a 13-year longitudinal observational study. J Pediatr Hematol Oncol (2005) 0.92
c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients. BMC Cancer (2011) 0.92